ORANGE COUNTY, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Gala Global, Inc. GLAG today announced that it has promoted Dr. Meqsood Rehman, 41, to the Chief Executive Officer of Gala Global, Inc., taking over from Timothy Madden, along with Joseph Earle as COO. Dr. Rehman will be taking over the position from Timothy Madden, who has assumed the responsibilities as the CEO of controlled environmental genomics (CEG), a subsidiary of Gala Global Inc. Dr. Rehman holds a Masters degree and PhD degree in Plant Science from the University of Idaho as well as a Post Doctorate degree from the University of Missouri-Columbia.
Dr. Rehman has a diversified scientific background with training with over ten years of industry experience in plant breeding, quantitative and molecular genetics, cytogenetics and project management.
"Today's senior management changes will represent the first of many stages of what will emerge as a new company that has clearly identified its target markets, geographic expansion goals and distribution channels," said Dr. Rehman, Chief Executive Officer of Gala Global, Inc. "I am honored and excited to have been selected as the key scientist to take Gala to its next level of growth and expansion and, in doing so, truly begin focusing on the enhancement of shareholder value. We are looking forward to updating our investors on a number of new and exciting developments in the days and weeks ahead," concluded Dr. Rehman..In addition, Mr. Joseph Earle, who has over 25 years of experience serving as CEO, COO and CFO of various technology companies, has taken over Dr. Rehman's former position as Chief Operating Officer of Gala Global, Inc. His expertise across various technology companies include pharmaceuticals, renewal energy, medical device, applications software, Internet based trading, hardware and software engineering and electronics manufacturing.
To be added to Gala Global's investor lists, please contact Bill Miller at 844-565-5665 or via email at bmiller@irpartnersinc.com.
About Gala Global Inc.
Gala Global, Inc., Anaheim, Calif., is a publicly-traded startup development company specializing in equity investments, debt financing and mergers and acquisitions (M&A) in the biotech industry. Gala Global's professional services group provides operational services and technologies that drive efficiencies in the market. Gala Global has industry-leading expertise helping companies make the most of their potential in an emerging market. Gala Global website: www.galaglobalinc.com.
Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company's public announcements.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
